Announcement on the progress of foreign investment of subsidiaries
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2018-003
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement on the Progress of Subsidiary's Foreign Investment
The board of directors and all directors of the company guarantee that the content of this announcement does not contain any False records, misleading statements or major omissions, and bear individual and joint responsibility for the authenticity, accuracy and completeness of its contents .
Basic Information on 1. Foreign Investment
On February 28, 2017, Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical"), a subsidiary of the Company, and Guilin Shangyuan Plant Products Co., Ltd., Beijing Huibaoyuan Enterprise Management Co., Ltd., Beijing Huibaoyuan Biotechnology Co., Ltd. (hereinafter referred to: beihui Bio) signed the "Agreement on Capital Increase and Equity Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." (hereinafter referred to as the "Master Agreement") and the "Performance Commitment Compensation Agreement", which agreed to meet the prerequisites of each period of investment Next, Jianfeng Pharmaceutical plans to invest in Beihui Bio in four phases by way of capital increase and equity transfer.
For details, please refer to the announcement -Pro 2017-003 "Announcement on Foreign Investment of Subsidiaries" published by the company in the designated information disclosure media "shanghai securities news", "china securities journal" and the website of Shanghai Stock Exchange (www.sse.com.cn ) on March 1, 2017.
Progress of Foreign Investment in 2.
(I) April 2017, Jianfeng Pharmaceutical has completed the first phase of investment in 80 million yuan, and the registered capital of Beihui Biology has increased from 80 million yuan to 100 million yuan, of which: Jianfeng Pharmaceutical accounts for 20% of the shares.
(II) The Master Agreement stipulates that the equity transfer part (7 million shares) in the second phase of investment shall be completed by March 31, 2018. In view of the fact that the 2017 audit of Beihui Biology is still in progress, the 2017 operating performance has not yet been determined. On March 29, 2018, the parties concerned held a teleconference and formed the minutes of the meeting, agreeing to convene the board of directors of Beijing Huibaoyuan Biotechnology Co., Ltd. and negotiate the equity transfer separately after the audit is completed and the actual business performance is determined.
3. Reference Document
Conference Call Minutes.
It is hereby announced that
Board of Directors of Zhejiang Jianfeng Group Co., Ltd.
March 30, 2008
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08